MBX
MBX Biosciences Inc.
$31.43
+$1.24(+4.11%)
43
Overall
60
Value
27
Tech
--
Quality
Market Cap
$34.31M
Volume
306.42K
52W Range
$4.81 - $44.89
Target Price
$62.55
Company Overview
| Mkt Cap | $34.31M | Price | $31.43 |
| Volume | 306.42K | Change | +4.11% |
| P/E Ratio | -0.6 | Open | $31.52 |
| Revenue | -- | Prev Close | $30.19 |
| Net Income | $-61.9M | 52W Range | $4.81 - $44.89 |
| Div Yield | N/A | Target | $62.55 |
| Overall | 43 | Value | 60 |
| Quality | -- | Technical | 27 |
No chart data available
Latest News
Wall Street Analysts Are Bullish on Top Healthcare Picks
Catie Powers•23 days ago
Analysts Offer Insights on Healthcare Companies: MBX Biosciences, Inc. (MBX) and REPRO-MED Systems (KRMD)
Catie Powers•a month ago
Analysts Offer Insights on Healthcare Companies: MBX Biosciences, Inc. (MBX) and REPRO-MED Systems (KRMD)
Catie Powers•a month ago
Microbix Advances Modernized Manufacturing for Kinlytic Clot-Buster Drug
TipRanks Canadian Auto-Generated Newsdesk•a month ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MBX | $31.43 | +4.1% | 306.42K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |